CLINICAL_TRIALS
trial_result
· 2015-08-03
Clinical Trial Update: Characteristics of Glargine in Type 2 Diabetics [Phase 1]
Summary
Phase 1 study evaluating characteristics of insulin glargine in people with Type 2 diabetes. Results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanderbilt University Medical Center | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2015-08-03